Live Breaking News & Updates on Maxpro capital acquisition corp

Stay informed with the latest breaking news from Maxpro capital acquisition corp on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Maxpro capital acquisition corp and stay connected to the pulse of your community

Maxpro Capital Acquisition (NASDAQ:JMAC) Stock Price Down 3.9%

Maxpro Capital Acquisition Corp. (NASDAQ:JMAC – Get Free Report) dropped 3.9% during mid-day trading on Wednesday . The stock traded as low as $0.40 and last traded at $0.46. Approximately 168,941 shares changed hands during mid-day trading, an increase of 128% from the average daily volume of 74,040 shares. The stock had previously closed at […]

Taiwan , Taipei , T-ai-pei , Maxpro-capital-acquisition-company-profile , Nasdaq , Maxpro-capital-acquisition-corp , Maxpro-capital-acquisition , Get-free-report , Capital-acquisition-stock-down , Capital-acquisition , Taipei-city

Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results

Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kunpeng , Guangdong , China , United-states , Guo-liang-yu , Peter-vozzo , Sean-leous , Matthew-plunkett , Nasdaq , Exchange-commission , Drug-administration , Maxpro-capital-acquisition-corp

Maxpro Capital Acquisition (NASDAQ:JMAC) Trading Down 6.7%

Maxpro Capital Acquisition Corp. (NASDAQ:JMAC – Get Free Report) fell 6.7% during trading on Friday . The company traded as low as $0.60 and last traded at $0.62. 217,313 shares traded hands during trading, an increase of 194% from the average session volume of 74,040 shares. The stock had previously closed at $0.66. Maxpro Capital […]

Taipei , T-ai-pei , Taiwan , Goldman-sachs-group-inc , Cubist-systematic-strategies , Millennium-management , Nasdaq , Maxpro-capital-acquisition-corp , Maxpro-capital-acquisition , Get-free-report , Systematic-strategies

Apollomics (NASDAQ: APLM) Market Momentum: Pipeline Potential, Market Trends, and Retail Insights

Apollomics, Inc. (NASDAQ: APLM) has seen a significant surge in its shares, rising by ~20% at time of writing, accumulating a staggering 58% gain since November 21st, 2023. Surprisingly, there haven’t been any noticeable press releases or filings to explain this sudden valuation shift, so it’s prompted a closer examination on our end. Fortunately enough, […]

China , Beijing , Chinese , Guo-liang-yu , World-health-organization , China-national-medical-products-administration , Gamestop , Drug-administration , Twitter , Entertainment-holdings , Nasdaq , Apollomics-inc

Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update

Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Beijing , China , Kunpeng , Guangdong , United-states , Peter-vozzo , Sean-leous , Guo-liang-yu , Maxpro-capital-acquisition-corp , Us-national-cancer-institute , China-national-medical-products-administration , Nasdaq

Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update

Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kunpeng , Guangdong , China , United-states , Beijing , Guo-liang-yu , Sean-leous , Peter-vozzo , Maxpro-capital-acquisition-corp , Securities-exchange , China-national-medical-products-administration , Nasdaq

Apollomics Reports First Half 2023 Financial Results and

Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC with MET exon14 skipping mutation expected second half...

Beijing , China , United-states , Kunpeng , Guangdong , Guo-liang-yu , Peter-vozzo , Sean-leous , Exchange-commission , Maxpro-capital-acquisition-corp , Nasdaq , Securities-exchange

Maxpro Capital Acquisition (NASDAQ:JMAC) Stock Price Down 1.3%

Shares of Maxpro Capital Acquisition Corp. (NASDAQ:JMAC – Get Free Report) dropped 1.3% during trading on Tuesday . The stock traded as low as $3.95 and last traded at $3.95. Approximately 5,648 shares were traded during trading, a decline of 92% from the average daily volume of 74,040 shares. The stock had previously closed at […]

Taipei , T-ai-pei , Taiwan , Maxpro-capital-acquisition-corp , Millennium-management , Cubist-systematic-strategies , Goldman-sachs-group-inc , Nasdaq , Maxpro-capital-acquisition , Get-free-report , Systematic-strategies

Head-To-Head Contrast: Apollomics (NASDAQ:APLM) vs. PhaseBio Pharmaceuticals (NASDAQ:PHAS)

Apollomics (NASDAQ:APLM – Get Rating) and PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Profitability This table compares Apollomics and PhaseBio Pharmaceuticals’ net margins, […]

Taiwan , Taipei , T-ai-pei , Ashutosh-chilkoti , Clay-bernardin-thorp , Phasebio-pharmaceuticals-inc , Maxpro-capital-acquisition-corp , Phasebio-pharmaceuticals , Get-rating , Phasebio-pharmaceutical , Bio-pharmaceuticals , Given-phasebio-pharmaceutical

Apollomics' (APLM) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of Apollomics (NASDAQ:APLM – Get Rating) in a report released on Thursday morning, The Fly reports. Apollomics Stock Performance Shares of APLM opened at $5.09 on Thursday. The stock’s 50-day moving average is $6.15. Apollomics has a 12 month low of $3.71 and a 12 month high […]

Taiwan , Taipei , T-ai-pei , Apollomics-company-profile , Maxpro-capital-acquisition-corp , George-kaiser-family-foundation , Geode-capital-management , Get-rating , Capital-management , Capital-acquisition , Taipei-city